Table 1.
Identified BRCA1/2 carriers
Gene | Cohort | Mutation | Effect | Age at diagnosis |
Norwegian ancestry |
Qualifying for predictive testing | Triple negative disease |
---|---|---|---|---|---|---|---|
BRCA1 | 1 | c.2019delA | Frameshift | 20-29 | No | No | Yes |
1 | c.1016dupAa | Frameshift | 30-39 | Yes | Yes | Yes | |
1 | del exon 3-16 | Deletion | 30-39 | No | No | No | |
1 | c.3228_3229delAGa* | Frameshift | 30-39 | Yes | No | No | |
1 | c.3178G > Ta | Nonsense | 40-49 | Yes | No | No | |
1 | c.3084_3094delTAATAACATTAa | Frameshift | 40-49 | Yes | No | Yes | |
1 | c.3228_3229delAGa | Frameshift | 40-49 | Yes | No | Yes | |
1 | c.5047G > Tb | Nonsense | 40-49 | Yes | Yes | Yes | |
1 | c.3607C > Tb | Nonsense | 50-59 | Yes | Yes | No | |
1 | c.4484G > Ac | Missense. Leads to skipping of exon 14 | 50-59 | Yes | No | No | |
2 | c.5407-2A > Gc | Frameshift, skipping of exon 23 | 60-69 | Yes | No | No | |
2 | c.1072delCb | Frameshift | 60-69 | Yes | No | No | |
2 | c.1556delAa | Frameshift | 40-49 | Yes | Yes | No | |
2 | c.5153G > Cb | Missense | 40-49 | Yes | Yes | No | |
2 | c.3756_3759delGTCT | Frameshift | 40-49 | No | No | No | |
2 | del exon 22 | Frameshift | 40-49 | No | No | Yes | |
2 | c.5309G > T | Missense | 30-39 | No | Yes | Yes | |
2 | c.697delGTa | Frameshift | 70- | Yes | Yes | Yes | |
2 | c.3228_3229delAGa | Frameshift | 50-59 | Yes | Yes | Yes | |
2 | c.445G > T | Nonsense | 40-49 | No | Yes | Yes | |
2 | c.1016dupAa | Frameshift | 50-59 | Yes | No | Yes | |
2 | c.5266dupC | Frameshift | 30-39 | No | Yes | No | |
2 | c.2989_29x0dupb | Frameshift | 50-59 | Yes | No | No | |
2 | c.1016dupAa | Frameshift | 30-39 | Yes | No | No | |
2 | c.1556delAa | Frameshift | 50-59 | Yes | Yes | No | |
2 | dup exon 13b | Frameshift | 50-59 | Yes | No | No | |
2 | c.5309G > T | Missense | 30-39 | No | No | Yes | |
2 | c.5503C > T | Nonsense | 50-59 | No | Yes | Yes | |
BRCA2 | |||||||
1 | c.4710delA | Frameshift | 30-39 | No | No | No | |
1 | c.3847_3848delGTa | Frameshift | 40-49 | Yes | No | No | |
1 | c.614delGc | Frameshift | 50-59 | Yes | Yes | No | |
2 | c.4936_4939delGAAAb | Frameshift | 40-49 | Yes | No | No | |
2 | c.3847delGTa | Frameshift | 40-49 | Yes | No | No | |
2 | c.9403delC | Frameshift | 40-49 | No | No | No | |
2 | c.5722delCTb | Frameshift | 40-49 | Yes | No | No | |
2 | c.6059_6062delAACAb | Frameshift | 30-39 | Yes | No | No | |
2 | c.5722delCTb | Frameshift | 50-59 | Yes | Yes | No | |
2 | c.4794_4797delCAAT | Frameshift | 40-49 | No | Yes | No | |
2 | c.614delGc | Frameshift | 30-39 | Yes | Yes | No | |
2 | c.7024C > T | Nonsense | 30-39 | No | Yes | No | |
2 | c.9699_9702delTATGc | Frameshift | 70- | Yes | No | No | |
2 | dup exon 20b | Frameshift | 40-49 | Yes | Yes | Yes |
1: Tested at Oslo University Hospital Ullevål (OUH-U)
2: Tested at other hospitals in South-Eastern Norway Regional Health Authority trust’s coverage area (SERHA)
aCommon Norwegian founder mutation38
bIdentified in 1-9 families at Department of Medical Genetics (DMG), OUH (unpublished data)
cNot identified previously at DMG, OUH
BC Breast cancer
OC Ovarian cancer